Esophageal Cancer Clinical Trial
Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients
Summary
The objective of this prospective, randomized controlled study is to ascertain whether the perioperative use of the FloTrac device to guide fluid and vasopressor management during esophagectomy improves patient outcomes. The primary outcome is cardiopulmonary complications; however, the secondary outcome of decreasing patient morbidity (acute renal injury, anastomotic leak, and overall length of both ICU (intensive care unit) and hospital stay.
Eligibility Criteria
Inclusion Criteria:
Patients 18 years of age or older
Patients undergoing primary resection of esophageal cancer and resultant esophagectomy.
Exclusion Criteria:
Patients < 55kg or > 140 kg, based on literature regarding accuracy of FloTrac.
Patients with sustained preoperative dysrhythmias, based on literature regarding accuracy of FloTrac (atrial flutter and/or atrial fibrillation).
Patients with diagnosed NYHA class III-IV failure or documented EF < 30%
Patients who are unable/unwilling to consent for study procedures
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Charleston South Carolina, 29461, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.